Q9BYF1 (ACE2_HUMAN) Homo sapiens (Human)

Angiotensin-converting enzyme 2 UniProtKBInterProSTRINGInteractive Modelling

805 aa; Sequence (Fasta) ; (Isoform 3)

Available Structures

192 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
ACE2 -Targeting Monoclonal Antibody as Potent and Broad-Spectrum Coronavirus Blocker Heteromer
Q695T7;
18-768
14×NAG; 10×NAG;ZN;
Assess
SIT1-ACE2-BA.2 RBD Heteromer
P0DTC2; Q9NP91;
19-768
16×NAG;NAG;3PH;ZN;
Assess
SIT1-ACE2-BA.5 RBD Heteromer
P0DTC2; Q9NP91;
19-768
16×NAG;NAG;3PH;ZN;
Assess
ACE2-B0AT1 complex Heteromer
Q695T7;
20-768
14×NAG; 10×NAG;3PH;ZN;
Assess
The 2019-nCoV RBD/ACE2-B0AT1 complex Heteromer
P0DTC2; Q695T7;
21-768
14×NAG;NAG; 10×NAG;LEU;ZN;
Assess
ACE2-B0AT1 complex, open conformation Heteromer
Q695T7;
21-768
Assess
Conformation 1 of S-ACE2-B0AT1 ternary complex Heteromer
P0DTC2; Q695T7;
21-768
58×NAG; 64×NAG;LEU;ZN;
Assess
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1 Heteromer
P0DTC2;
21-731
Assess
The complex structure of RshSTT182/200 RBD bound to human ACE2 Heteromer
19-619
NAG;ZN;
Assess
Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04 Heteromer
17-614
NAG;NAG;NAG;
Assess
Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
19-615
NAG;CL;ZN;
Assess
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 Heteromer
P0DTC2;
19-615
ZN;CL;NAG;
Assess
Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 Heteromer
P0DTC2;
19-615
NAG;ZN;CL;NAG;
Assess
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor Heteromer
P59594;
19-615
NAG;NAG;ZN;CL;
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … Heteromer
P59594;
19-615
ZN;CL;
Assess
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… Heteromer
P59594; Q56NL1;
19-615
NDG;ZN;CL;NAG;
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594;
19-615
ZN;CL;
Assess
Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
19-615
NAG;CL;ZN;XX5;
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594; Q56NL1;
19-615
ZN;CL;
Assess
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… Heteromer
P59594; Q56NL1;
19-615
ZN;CL;
Assess
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunoc… Heteromer
P0DTC2;
19-615
NAG;NAG;NAG;NAG;NAG;ZN;CL;NAG;
Assess
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 Heteromer
P0DTC2;
19-615
NAG;NAG;NAG;NAG;ZN;SO4;
Assess
Crystal structure of human ACE2 and GX/P2V RBD Heteromer
A0A6G6A2Q2;
19-615
ZN;
Assess
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2 Heteromer
P0DTC2;
19-615
NAG;ZN;EDO;CL;
Assess
SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 Heteromer
P0DTC2;
19-615
NAG;ZN;
Assess
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 … Heteromer
P0DTC2;
19-615
NAG;ZN;
Assess
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex w… Heteromer
A0A6B9WHD3;
19-615
NAG;NAG;
Assess
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex w… Heteromer
A0A6B9WHD3;
19-615
NAG;NAG;
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state Heteromer
P0DTC2;
19-615
Assess
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex Heteromer
P0DTC2;
19-615
ZN;CL;NAG;
Assess
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex Heteromer
P0DTC2;
19-615
ZN;NAG;
Assess
SARS-CoV-2 S-ACE2 complex Heteromer
P0DTC2;
19-615
18×NAG; 36×NAG;
Assess
Cryo-EM structure of Omicron S-ACE2, C2 state Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C2b Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state Heteromer
P0DTC2;
19-615
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/AC… Heteromer
P0DTC2;
19-615
Assess
The structure of FC08 Fab-hA.CE2-RBD complex Heteromer
P0DTC2;
19-615
NAG;
Assess
Cryo-EM structure of human ACE2 and GD/1/2019 RBD Heteromer
A0A7D6PMV8;
19-615
ZN;NAG;
Assess
SARS-CoV-2 Delta S-ACE2-C3 Heteromer
P0DTC2;
19-615
Assess
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD Heteromer
A0A6G6A2Q2;
19-615
ZN;NAG;
Assess
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C2a Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-RBD-ACE2 Heteromer
P0DTC2;
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
19-615
Assess
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state Heteromer
P0DTC2;
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
19-615
Assess
SARS-COV-2 Spike RBDMACSp6 binding to hACE2 Heteromer
P0DTC2;
19-615
NAG;
Assess
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1 Heteromer
P0DTC2;
19-615
Assess
SARS-COV-2 Spike RBDMACSp25 binding to hACE2 Heteromer
P0DTC2;
19-615
NAG;
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C1 Heteromer
P0DTC2;
19-615
Assess
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state Heteromer
P0DTC2;
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
19-615
Assess
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant Heteromer
P0DTC2;
19-615
NAG;
Assess
S-ECD (Omicron) in complex with PD of ACE2 Heteromer
P0DTC2;
19-615
23×NAG; 45×NAG;
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) Heteromer
P0DTC2;
19-615
NAG;ZN;CL; 49×NAG;
Assess
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) Heteromer
P0DTC2;
19-615
NAG; 53×NAG;ZN;CL;
Assess
SARS-CoV-2 Kappa variant spike protein in C3 state Heteromer
P0DTC2;
19-615
Assess
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex Heteromer
P0DTC2;
19-615
ZN;NAG;
Assess
SARS-CoV-2 Kappa variant spike protein in C2b state Heteromer
P0DTC2;
19-615
Assess
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2 Heteromer
19-614
NAG;ZN;CL;NAG;NA;
Assess
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 Heteromer
P0DTC2;
19-614
NAG;ZN;
Assess
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 Heteromer
P0DTC2;
19-614
NAG;NAG;EDO;ZN;
Assess
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T2… Heteromer
P0DTC2;
19-614
NAG;
Assess
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 Heteromer
P0DTC2;
19-614
NAG;ZN;
Assess
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2 Heteromer
19-614
NAG;NAG;ZN;CL;
Assess
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;
Assess
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 Heteromer
P0DTC2; P59594;
19-614
NAG;NAG;ZN;CL;EDO;NAG;
Assess
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S1… Heteromer
P0DTC2;
19-614
NAG;
Assess
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 Heteromer
P0DTC2;
19-614
NAG;ZN;
Assess
Crystal structure of Omicron BA.3 RBD complexed with hACE2 Heteromer
P0DTC2;
19-614
NAG;NAG;NAG;ZN;NAG;
Assess
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab Heteromer
P0DTC2;
19-614
NAG; 30×EDO; 22×CL;ZN; 13×NAG;
Assess
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human AC… Heteromer
P0DTC2;
19-614
ZN;NAG;
Assess
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immuni… Heteromer
P0DTC2;
19-614
NAG;CL;SO4;NA;PG5;ZN;NAG;PGE;
Assess
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;
Assess
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;
Assess
SARS-CoV-2 Omicron BA.2.75 RBD in complex with ACE2 Heteromer
P0DTC2;
19-614
12×GOL;NAG;CL;PGE;
Assess
Crystal structure of Omicron BA.2 RBD complexed with hACE2 Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;NAG;
Assess
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecov… Heteromer
P0DTC2;
19-614
NAG;NAG;SO4;TRS;PEG;ZN;CL;GOL;
Assess
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein i… Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;
Assess
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 Heteromer
P0DTC2;
19-614
NAG;ZN;
Assess
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2 Heteromer
A0A6B9WHD3;
19-614
NAG;NAG;ZN;
Assess
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in co… Heteromer
P0DTC2;
19-614
NAG;
Assess
Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human … Heteromer
Q6Q1S2;
19-614
NAG;
Assess
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in … Heteromer
P0DTC2;
19-614
NAG;NAG;NAG;ZN;
Assess
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein… Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;NAG;
Assess
The crystal structure of RshSTT182/200 RBD-insert2-T346R-Y496G mutant in complex with human ACE2 Heteromer
19-614
NAG;ZN;
Assess
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2 Heteromer
19-614
NAG;ZN;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
P0DTC2;
19-614
37×NAG; 13×NAG;
Assess
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 Heteromer
P0DTC2;
19-614
NAG; 53×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2;
19-614
30×NAG; 29×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2;
19-614
43×NAG; 14×NAG;
Assess
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2;
19-614
NAG; 55×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
19-614
18×NAG; 42×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 Heteromer
P0DTC2;
19-614
18×NAG; 26×NAG;
Assess
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2;
19-614
NAG; 48×NAG;
Assess
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2)… Heteromer
P0DTC2;
19-614
NAG;NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 Heteromer
P0DTC2;
19-614
18×NAG; 26×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
P0DTC2;
19-614
18×NAG; 26×NAG;
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 Heteromer
P0DTC2;
19-614
NAG; 44×NAG;
Assess
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2;
19-614
NAG; 56×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2;
19-614
29×NAG; 26×NAG;
Assess
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (AC… Heteromer
P0DTC2;
19-614
NAG;NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
19-614
18×NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzym… Heteromer
P0DTC2;
19-614
29×NAG; 26×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2;
19-614
38×NAG; 16×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
19-614
NAG;
Assess
Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 … Heteromer
P0DTC2;
19-614
NAG;NAG;NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
19-614
18×NAG; 28×NAG;
Assess
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… Heteromer
P0DTC2;
19-614
NAG;NAG;
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2;
19-614
NAG; 46×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2;
19-614
30×NAG;NAG; 19×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enz… Heteromer
P0DTC2;
19-614
31×NAG; 17×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
19-614
18×NAG; 32×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2;
19-614
37×NAG; 15×NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
P0DTC2;
19-614
31×NAG; 13×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused… Heteromer
P0DTC2;
19-614
NAG;
Assess
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 … Heteromer
P0DTC2;
19-614
NAG;NAG;NAG;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
19-614
18×NAG; 28×NAG;
Assess
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD Heteromer
P0DTC2;
19-614
NAG;ZN;
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
19-614
18×NAG; 28×NAG;
Assess
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region Heteromer
P0DTC2;
20-615
ZN;NAG;
Assess
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 Heteromer
P0DTC2;
20-615
NAG; 36×NAG;ZN;
Assess
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused re… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement) Heteromer
P0DTC2;
19-614
NAG;ZN;NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 Heteromer
P0DTC2;
19-614
18×NAG; 36×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 Heteromer
P0DTC2;
19-614
18×NAG; 26×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… Heteromer
P0DTC2;
19-614
23×NAG; 24×NAG;ZN;
Assess
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 Heteromer
P0DTC2;
19-614
18×NAG; 42×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refin… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutat… Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;
Assess
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 Heteromer
P0DTC2;
19-614
18×NAG; 28×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused r… Heteromer
P0DTC2;
19-614
NAG;
Assess
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab Heteromer
P0DTC2;
19-614
NAG;NAG;ZN;
Assess
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutat… Heteromer
P0DTC2;
19-614
15×NAG; 33×NAG;ZN;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… Heteromer
P0DTC2;
19-614
22×NAG; 23×NAG;ZN;
Assess
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab Heteromer
P0DTC2;
19-613
EDO; 11×CL;ZN;NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction Heteromer
P0DTC2;
19-613
Assess
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2 Heteromer
P0DTC2;
19-613
12×NAG; 21×NAG;CL;ZN;
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) Heteromer
P0DTC2;
21-615
26×NAG; 30×NAG;
Assess
SARS-CoV-2 Omicron Variant RBD complexed with ACE2 Heteromer
P0DTC2;
19-613
NAG;CL;ZN;
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound Heteromer
P0DTC2;
19-613
23×NAG;ZN;
Assess
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2 Heteromer
P0DTC2;
19-613
NAG; 48×NAG;ZN;
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) Heteromer
P0DTC2;
19-613
NAG;NAG;ZN;
Assess
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 Heteromer
P0DTC2;
19-613
ZN;NAG;
Assess
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
P0DTC2;
19-613
ZN;NAG;
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and … Heteromer
P0DTC2;
21-615
32×NAG; 29×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound Heteromer
P0DTC2;
19-613
Assess
SARS-CoV-2 B.1.1.7 S-ACE2 complex Heteromer
P0DTC2;
19-613
16×NAG; 27×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with T-ACE2 Heteromer
P0DTC2;
21-615
35×NAG; 34×NAG;
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
P0DTC2;
19-613
NAG;NAG;ZN;
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and … Heteromer
P0DTC2;
21-615
32×NAG; 29×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound Heteromer
P0DTC2;
19-613
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) Heteromer
P0DTC2;
21-615
27×NAG; 28×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction Heteromer
P0DTC2;
19-613
Assess
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2 Heteromer
P0DTC2;
19-613
NAG;CL;ZN;NAG;
Assess
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain Heteromer
P0DTC2;
19-613
ZN;NAG;
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and … Heteromer
P0DTC2;
21-615
27×NAG; 28×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 Heteromer
P0DTC2;
19-613
18×NAG; 34×NAG;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinemen… Heteromer
P0DTC2;
19-613
NAG;
Assess
Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
P0DTC2;
19-613
ZN;NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
P0DTC2;
19-613
NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
P0DTC2;
19-613
14×NAG; 20×NAG;
Assess
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development Heteromer
P0DTC2;
19-613
14×NAG; 12×NAG;
Assess
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound Heteromer
P0DTC2;
19-613
39×NAG;CL;ZN;
Assess
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2 Heteromer
P0DTC2;
19-613
CL;ZN;NAG;
Assess
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound Heteromer
P0DTC2;
19-613
39×NAG;CL;ZN;
Assess
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 Heteromer
P0DTC2;
21-615
NAG;
Assess
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 Heteromer
P0DTC2;
21-615
NAG;
Assess
SARS-COV-2 Spike RBDMACSp36 binding to hACE2 Heteromer
P0DTC2;
19-612
NAG;
Assess
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
P0DTC2;
20-613
NAG;ZN;
Assess
Neutral Omicron Spike Trimer in complex with ACE2 Heteromer
P0DTC2;
19-612
16×NAG;NAG; 34×NAG;
Assess
Neutral Omicron Spike Trimer in complex with ACE2. Heteromer
P0DTC2;
19-612
NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound Heteromer
P0DTC2;
21-613
20×NAG; 40×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound Heteromer
P0DTC2;
21-613
24×NAG; 42×NAG;
Assess
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound Heteromer
P0DTC2;
21-613
17×NAG; 36×NAG;
Assess
The co-crystal structure of ACE2 with Fab Heteromer
23-613
ZN;
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state Heteromer
P0DTC2;
35-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… Heteromer
P59594; Q56NL1;
56-615
NDG;ZN;CL;NAG;
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… Heteromer
P59594; Q56NL1;
56-615
NDG;ZN;CL;NAG;
Assess
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles Heteromer
P59594;
19-562
NAG;NAG; 11×NAG;NAG;
Assess
Importin alpha bound to the C-terminus of ACE2 Heteromer
P52293;
768-774
Assess
NMR structure of human ACE2 21-42 fragment in HFIP/water 50/50 v/vmonomer21-42
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6m17.1.Bmonomer0.8421-768
NAG;ZN;100.00
Assess
7mjm.1 Heteromer
Q9BYF1; P0DTC2;
0.7719-614
NAG;99.45
Assess
7kj2.1 Heteromer
P0DTC2;
0.7221-613
NAG;NAG;99.67
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 37dwx.1.Bmonomer0.774-422
ZN;99.12
Assess